In his view, the IL-7 antagonism of TGF-β and the resulting block of fibrosis observed in an experimental model (bleomycin-induced lung fibrosis) could represent an interesting aspect of IL-7 activity which remains to be demonstrated in the clinic [77]. The gene discussed is IL7; the disease is pulmonary fibrosis.